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ABSTRACT. Objectives: To determine if an association exists in Durham 
County between time the North Carolina Medicaid care management program 
(CCNC) has been in place and changes in service utilization patterns among 
asthmatic children, and to assess the relationship between program duration and 
racial disparities. 
Methods: CCNC program years 2000,2001, 2002 were evaluated. Individuals 
aged 0-18 with an asthma Medicaid claim (ICD9 code 493.xx) emolled in CCNC 
were eligible. Incidence rate ratios and likelihood rates were calculated for 
outpatient, ED and hospital use, controlling for age, race, gender, pregnancy, 
welfare status and person-months. Analysis was also done with sample stratified 
by race. 
Results: Compared to 2000, the adjusted rate of outpatient use was 1.317 times 
greater in 2001 (p=0.007) and 1.216 times greater in 2002 (p=0.032). Compared 
to 2000, the adjusted rate of emergency department use was 1.428 times greater in 
2001 (p=0.034), 1.693 times greater in 2002 (p=O.OOl). There were no significant 
differences in inpatient utilization by time period or race. Although African 
American and Hispanic outpatient use increased more than Caucasians over time, 
an initial disparity remained statistically significant, with Caucasians being more 
likely to use ambulatory care than either race. African Americans increased their 
ED use over time, but there were no statistically significant disparities in ED use. 
Conclusions: CCNC emollee use of ambulatory care increased from year 2000 to 
2002; however, this utilization began and remained unequal among races. ED use 
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rose, rather than decreasing. Evalnation across more program years is necessary 
to determine the long-term effect on ED utilization and cost. 
Introduction 
Asthma is the most common chronic condition of childhood. 1 Ranking as 
the third most common cause of hospitalization for children under fifteen, 2 asthma 
was responsible for over 650,000 pediatric emergency room visits in 1999.3 The 
prevalence of pediatric asthma is higher among minorities and low-income 
individuals;4 specifically, the Medicaid population is more likely to have an 
emergency department visit or hospitalization for asthma than those with private 
insurance5 (See Addendum A) 
Numerous studies have documented that there is a disproportionate burden 
of asthma among racial/ethnic minorities6 .7·8 Within the Medicaid population, 
African American children with asthma are more likely than Caucasians to visit 
the emergency department or be hospitalized for asthma9 A recent study among 
children with asthma enrolled in a state Medicaid PCCM or fee-for service 
program found that black children were 75% more likely and Hispanic children 
were 56% more likely than white children to have had 2:1 asthma ED visits per 
year, after controlling for case mix, provider type, disability status, age and 
gender. 10 
In an attempt to improve patient quality oflife while decreasing high-cost 
utilization of the emergency department and hospital, insurance companies and 
state Medicaid programs began to embrace case management as a possible 
solution. 11 Case management, a system that identifies high risk or high utilization 
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patients and then implements individualized care plans, appears to work, at least 
for asthma-related quality of life; several randomized controlled trials have 
determined that case management has decreased asthma symptom days, improved 
lung function and decreased school absenteeism. 12•13•14 Evidence regarding case 
management and service utilization, however, is less conclusive. (See Addendum 
B) 
Case management also seems effective for low-income children with 
asthma. A randomized, controlled, multi-site trial evaluated a family-focused 
asthma intervention, which included family and PCP education, as well as regular 
case worker follow-up. This intervention, designed for inner-city children 5 to II 
years old with moderate to severe asthma, living in inner-city census tracts where 
at least 20% of the population was below the federal poverty level, resulted in 
fewer symptom days than control. 15 A controlled trial of asthmatic children 
enrolled in Medicaid found that participation in a comprehensive asthma 
intervention including education and case workers resulted in decreased ED and 
hospital visits, as well as decreased health care charges. 16 Also, preliminary data 
from the Harlem Children's Zone Asthma Initiative (HCZAI), which manages 
children twelve and younger with asthma through home visits by a pediatric team, 
supports case management; children enrolled in the intervention had fewer missed 
school days and ED visits. 17 
Community Care of North Carolina (CCNC), a community-based care 
management program, was created in 1998 by the North Carolina Division of 
Medical Assistance (Medicaid). The program is an outgrowth of the state's 
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existing primary care case management system, Carolina ACCESS. CCNC 
emphasizes case management, with networks of local providers working 
collaboratively to coordinate patient care. As of December 2002, there were 12 
networks covering over 250,000 Medicare beneficiaries. At present, CCNC is 
specifically targeting individuals with high levels of health expenditures (such as 
those that exhibit high emergency department utilization rates) or those with 
chronic conditions that can lead to high costs. The methods employed to improve 
care quality and reduce costs for these patients include PCP-centered care and 
increased preventive services. Case managers also identify and help to resolve 
barriers to appropriate service use for individual patients. (See Addendum C) 
Asthma is one high-cost chronic condition that CCNC has been targeting. 
A study examining the four systems of North Carolina Medicaid delivery 
(Carolina ACCESS, CCNC, HMOs and fee-for-service) in the treatment of 
persistent pediatric asthma from 1998 to 1999 reported that 67% of enrollees in 
CCNC were receiving appropriate long-term control asthma medications, 
compared with 58% in Carolina ACCESS, 53% in fee-for-service and 53% in the 
HMOs. These significant differences suggested that pediatric enrollees in CCNC 
were more like! y to have proper asthma treatment than other groups. 18 
In a state-wide evaluation ofCCNC from January 2000 to December 
2002, children with asthma had lower total health care costs per member per 
month (pmpm) than those enrolled in Carolina ACCESS during the same time 
period. Emergency department utilization was also substantially lower for CCNC 
asthmatic children than ACCESS children, with 34% fewer per-enrollee 
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emergency department visits and 21% fewer per-emollee astlnna-related inpatient 
hospitalizations in 2002. Average number of emergency department visits per 
1,000 children with asthma emolled in CCNC also decreased during this time 
period, with 843 such visits in 2000, 808 visits in 2001 and 679 visits in 2002. 
Decreases were also seen in the average number of inpatient admissions per 1,000 
pediatric astlnnatic enrollees; there were 158 visits per 1,000 enrollees in 2000, 
decreasing to 128 in 2001 and 97 in 2002. However, it is important to note that 
no effort was made to control for astlnna severity in the above study. 
The average cost pmpm for children with astlnna varied significantly by 
geographic location, however, ranging from $152.79 to $402.80 in 2002. Durham 
County had an average pmpm cost of $337.64 during 2002, which ranks among 
the higher pmpm costs for individual counties. 19 Therefore, it is important to 
evaluate the program on the county level, to assure that Durham County is having 
a similar impact on emergency department and hospital use for pediatric 
asthmatics to those found statewide. 
This study will assess whether: 1) there is an association in Durham 
between length of time children with astlnna were emolled in CCNC and changes 
in patterns of service utilization from 2000 to 2002, and 2) a racial disparity exists 
between groups enroiied in CCNC, and CCNC has racial differences in 
outpatient, emergency department and hospital utilization over time. 
HYPOTHESIS: Ideally, under the CCNC plan, with its improved provider 
practice and care management activities, Durham County will experience an 
increase in ambulatory care over time among children with astlnna enrolled in the 
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program, with decreases in emergency department and hospital use. Further, 
racial disparities, if any exist, should decrease or disappear over time among 
enrollees in CCNC. 
Methods 
Overview 
To test the hypothesis that utilization patterns for the study population 
would improve over time, changes in utilization were examined over a three-year 
time period, from 2000 to 2002, controlling for changes in case mix over that time 
period. This three-year time period was chosen to correlate with the earlier state-
wide evaluation performed by the Sheps Center. Since the hypothesis was that 
improved provider practice, care management, and patient education would lead 
to greater use of ambulatory care and decreased inpatient and emergency 
department utilization, utilization for these three types of services was examined. 
In order to have a clearer understanding of any possible changes in outcome 
utilization, an overall visit rate ratio, the likelihood of a visit and a visit rate ratio 
amongst service utilizers was calculated. Using this combination of outcomes, it 
is possible to determine if a change in overall outcome rate is due to a change in 
the number of individuals using the service (likelihood term), due to a change in 
the rate amongst users (user rate) or both. To examine the impact of race on 
utilization, the outcome of utilization was stratified by race groups. Finally, to 
take into account the impact of trends in service utilization that were not specific 
to our study population, the findings on ED utilization were compared to county-
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level trends in ED utilization. County-level trends in outpatient and inpatient 
utilization were not evaluated due to difficulties obtaining all relevant data. 
Study methods and design were approved through both the DUMC 
Institutional Review Board (Registry# 6656-05-ZROER) and the University of 
North Carolina School of Public Health Institutional Review Board (Reference# 
05-2477). 
Data 
Two sources of data were used for this study. The Carolina ACCESS 
Emollment database provides descriptive and program history data for all Durham 
County Medicaid participants emolled in Community Care of North Carolina. 
This database includes emollee name, date of birth, gender, race, address, phone, 
program status, primary care provider facility, personal Medicaid ID number 
(PID), Social Security number (SSN), emollee status in the program each month 
(started the program, continued to be active, left the program), as well as the type 
of Medicaid program under which the individual was entered. This information is 
collected by DSS workers; it is important to note that race/ethnicity information is 
based on the workers' impression, and not self-identification. As emollees sign 
up or renew Medicaid coverage, their data is stored in the program's eligibility 
information system and transferred to the state Community Care of North 
Carolina Office. These data are then forwarded to Duke Community Health 
Network and added the Emollment database. There are approximately 41,000 
emollees in the Emollment database. 
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The Carolina ACCESS Encounter database includes all outpatient, 
inpatient and emergency department encounters through Duke University Medical 
Center (DUM C), Durham Regional Hospital, Lincoln Community Health Center, 
and DUMC-associated outpatient clinics for emollees of Community Care of 
North Carolina. Lincoln Community Health Center data are not available for all 
years, specifically the second half of 2004 and 2005; however the data is complete 
for all three years of interest for this study. Also, any outpatient visits outside of 
Lincoln Community Health Center and the DUMC system would not be captured 
by this data. These missing data are unlikely to be significant, as during this time 
period, emollment in CCNC required choosing a PCP through Lincoln or DUMC, 
and special permission was required to go elsewhere. Further, most specialty care 
for these emollees would likely be provided at either of these two locations. As 
DUMC controls all inpatient facilities in Durham County, this database represents 
all Durham County inpatient and emergency department use by CCNC emollees. 
This database includes emollee PID number, start and end dates of the encounter, 
location and CPT codes, primary and secondary ICD-9 codes and provider 
information, such as provider name. Initially, Medicaid claims data were to be 
used for this analysis; however, the data did not arrive from the Division of 
Medical Assistance in time for this evaluation. Therefore, the Carolina ACCESS 
Encounter database was used in its stead. Medicaid claims data would have 
provided information about encounters that were located outside of Durham 
County, as well as information regarding health care charges; this information is 
not available in the Encounter database. 
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The following variables were included in the analysis: gender, age, race, 
number of months active in program, welfare, pregnancy and disability status and 
provider. Gender was coded as a male/female. Age during year of interest was 
calculated from date of birth. Race, which was considered important to answer 
the hypotheses, was coded as African American, Asian, Caucasian, Hispanic and 
Other. As mentioned above, race was based on case worker impression; 
therefore, there may be some discrepencies, especially between Caucasian and 
Hispanic or differences in race determination from year to year. Number of 
months active in the program, a necessary control, was calculated from enrollee 
status information. As socioeconomic status is a risk factor for an asthma 
diagnosis, welfare status was extracted from the type of Medicaid program under 
which enrollees entered the program. As pregnancy and disability status may 
affect service utilization, this information was also extracted from the type of 
Medicaid program the under which enrollees entered CCNC. Welfare, pregnancy 
and disability status were coded as yes/no variables. 
Subject Selection 
Subjects were identified as asthmatic by the North Carolina Division of 
Medical Assistance (DMA), who provided a list of all North Carolina Medicaid 
enrollees with an asthma diagnosis (ICD9 code 493.xx) in their Medicaid claims 
from 1998 to 2005. These individuals were linked to the Carolina ACCESS 
Enrollment database via Medicaid identification number and SSN. Children with 
asthma appropriate for inclusion in the study were then identified as all 
individuals under 18 years of age for each year of interest. This created a cohort 
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for 2000, 2001, and 2002. As there were too few individuals emolled during all 
three years of interest (45 out of the 1615 emollees), a true cohort analysis could 
not be performed. Instead, each individual was treated as a unique case in each 
year. Conversely, because the number of individuals emolled during all three 
years was so small, the analysis did not have to take into account possible 
collinearity between outcome values for the same person over multiple years. 
Collinearity is a problem that occurs when one set of data is highly correlated to 
another set of data, such that one set can be predicted by another. However, due 
to the small numbers of individuals emolled all three years, there was no need to 
account for the a person's outcome values one year predicting the outcome values 
for another year. 
These year-specific cohorts were then linked via Medicaid identification 
number to the Carolina ACCESS Encounter database. This allowed the creation 
of a new dataset, which included all children with asthma emolled in CCNC for 
the year of interest, demographic information including age, race and gender, 
PCP, pregnancy, disability and welfare status, number of emergency department, 
hospital and outpatient visits, and the number of months each emollee was active 
in the program. 
Data Analysis 
Univariate, bivariate and multivariate analyses were performed using the 
program STAT A. A p-value less than 0.05 was considered significant. Based on 
the univariate analysis, some recoding was done (e.g., collapsing the racial 
categories of "other" and "Asian"). Statistical tests were chosen based on 
11 
variable type (categorical versus continuous) and number of variable categories. 
Bivariate analysis was used to test for collinearity among the independent 
variables and potential controls (none was detected) and to determine which 
variables should be included as controls in the multivariate analyses. Poisson 
regressions with controls were then performed to determine the effect of program 
year on the volume of emergency department, outpatient and inpatient utilization, 
with the log of active months as the offset and robust standard error calculations. 
This allowed for calculation of incidence rate ratios controlled for the number of 
people enrolled in the program and the number of active months in the program. 
These outcomes were also evaluated on a yes/no basis to determine the number of 
enrollees utilizing the services. Logistic regressions were performed to analyze 
the effect of program year on this outcome. Subjects were determined to be 
"users" for each outcomes if they had any emergency department, outpatient or 
inpatient visits, respectively. A subject level "user-rate" for each outcome per 
year was then created, consisting of the number of visits per user divided by the 
number of active months the subject was in the program. In other words, this 
user-rate included only those individuals with at least one outcome visit. Poisson 
regressions were then performed to determine the effect of program year on the 
user-rate of emergency department, outpatient and inpatient utilization, with the 
log of active months as the offset and robust standard error calculations. This 
allowed for calculation of "user" incidence rate ratios controlled for the number of 
people enrolled in the program and the number of active months in the program. 
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Each regression was also performed stratified by race, to determine if there were 
any racial differences in outcome utilization over time. 
County-level yearly emergency department utilization rates were 
determined by calculating the ratio of the number of billed emergency department 
visits in Durham County to the year-specific county population. Billed 
emergency department visits were obtained through DUMC and Durham 
Regional Hospital encounter data, and yearly county population data were 
obtained from North Carolina State Center for Health Statistics20 
Results 
Sample Description and Bivariate Analysis 
Using the eligibility criteria outlined above, 429 eligible enrollees were 
identified for the year 2000, 552 enrollees for the year 2001 and 724 enrollees for 
the year 2002. Participant demographic characteristics for each program year are 
provided in Table I. Bivariate regression showed the differences in age 
distribution, percent pregnant, and percent on welfare across the three years to be 
statistically significant (p<0.05). Mean months active in the program were similar 
across program years. 
Three types of health services utilization outcomes were assessed: 
outpatient, emergency department and hospitalization. For each of these types of 
health service, mean visits per enrollee, percentage of enrollees with one or more 
such visits during the year, and mean visits per active months among those 
participants with such visits were examined. These outcomes are discussed below 
and summarized in Tables 2 through 5 and Figure I. 
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Mean outpatient visits increased from 6.44 in 2000 to 8.89 in 2001, with a 
slight decrease to 8.06 visits in 2002 (Table 2). This upward trend was significant 
(p=0.0021 ). The percentage of participants with one or more outpatient visits 
increased from 77.62% in 2000 to 88.22% in 2001, with 84.81% in 2002. This 
upward trend was also significant (p=O.OOO). Among participants with one or 
more outpatient visits, there was no significant difference in visits per active 
months among program years. 
Trends in outpatient visits differed amongst races. Like the enrollees 
overall, African Americans showed an increased trend in mean outpatient visits 
(p=0.0154), and in percentage of enrollees using ambulatory services (p=0.003), 
but no difference in user outpatient rate, suggesting an increase in use due to 
increased number of enrollees utilizing outpatient services. Hispanics showed an 
increased trend in the percentage of individuals having any outpatient visit 
(p=O.OOO), but no change in mean outpatient visits or outpatient user rate. 
Caucasians and those categorized as Other did not show a change in outpatient 
utilization over time. 
Mean emergency department visits increased from 0.23 in 2000 to 0.34 in 
2001 and 0.44 in 2002 (Table 3). This upward trend was significant (p=0.0005). 
Also, the percentage of participants with one or more emergency department 
visits increased from 15.85% in 2000 to 20.83% in 2001 and 23.07% in 2002. 
This upward trend was significant (p=0.013). However, among participants with 
one or more emergency department visits, there was no significant difference in 
visits per active months across program years. 
14 
Trends in emergency department utilization differed amongst races. 
African Americans showed an increased trend in mean number of ED visits 
(p=0.006) in percentage of enrollees using ED services (p=0.012), but no 
difference in user ED rate, suggesting an increase in use due to increased number 
of enrollees utilizing ED services. Caucasians showed an increased trend in 
percentage of enrollees using ED services (p=O.Ol 0). Hispanics showed an 
increased trend in user ED rate (p=0.0424). Those categorized as Other had no 
change in emergency department utilization. 
Average number of emergency department visits for all Durham County 
was also calculated, and the rates of increase compared with those of the Durham 
County pediatric asthmatics enrolled in CCNC (Table 4). Emergency department 
utilization for Durham County increased 9.05% from 2000 to 2002, while 
Durham County pediatric asthmatics enrolled in CCNC increased their emergency 
department utilization by 96.0%. 
There were no significant differences in mean inpatient visits, percentage 
of participants with one or more inpatient visits, or inpatient visits per active . 
months among participants with one or more inpatient visits across program 
years, either for the group as a whole or specific racial/ethnic category (Table 5). 
Mean outcomes for each year were evaluated by race (Tables 6 through 8). 
Mean outpatient use did not vary significantly between racial categories in years 
2000 and 2001; however, significant differences were seen in year 2002 
(p=0.0466), with Caucasians having an increased mean number of outpatient 
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visits (Table 6). Mean emergency department and inpatient utilization did not 
vary significantly between racial categories in ail program years (Tables 7 and 8). 
Coiiinearity between program year and control variables was tested. None 
of the variables were found to be highly correlated to each other. Age, race, 
pregnancy and welfare status were significantly related to the outcomes as weii as 
to program year, and were therefore controiied for in the multivariate analyses. 
Gender was not correlated to the program years, but was correlated to the 
outcomes; since there were sufficient degrees of freedom, it was included in the 
multivariate analysis. The number of active months in the program was also 
included in the analyses as an offset. 
Multivariate Analyses 
Outpatient Utilization 
Outpatient utilization is presented in Tables 9 through I 1 and discussed 
below. 
The multivariate analysis confirmed that the overaii volume of outpatient 
utilization increased from 2000. The rate of outpatient use was 1.317 times greater 
in the year 2001 than in 2000 (p=0.007) and 1.216 times greater in the year 2002 
than in 2000 (p=0.032) when adjusted for age, gender, race, pregnancy and 
welfare status, and controiied for person-months (Table 9). The chance of having 
an outpatient visit increased from the year 2000, suggesting an increase in the 
number of participants using ambulatory services. Overaii, when adjusted for 
other variables, participants were 2.386 times more likely to have an outpatient 
visit in 2001 (p=O.OOO) and 1.439 times more likely in 2002 (p=0.025) when 
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compared with 2000 (Table 1 0). Among those with one or more outpatient visit, 
there was no difference in outpatient use from 2000 to 2001 or 2002, suggesting 
that the rate of outpatient use did not change among those utilizing ambulatory 
services (Table 11 ). Therefore, the overall increase rate of outpatient utilization is 
due to an increased number of enrollees accessing ambulatory care and not an 
increased rate amongst users. 
There were some differences in outpatient utilization among racial groups. 
African Americans were 2.125 times more likely to have an outpatient visit in 
2001 (p=O.OOO) and 1.769 times more likely to have an outpatient visit in 2002 
(p=0.002) when compared with the year 2000. African Americans did not have 
an overall increased rate of outpatient use compared with 2000; however this 
value was near significance in 2001. 
Hispanics showed an increased rate of outpatient utilization; in 2002, the 
rate of use for Hispanic patients was 2.033 times greater than in the year 2000 
(p=0.016). This overall increase in rate seems due to increased numbers of 
Hispanics accessing ambulatory care. Hispanics were especially more likely to 
have an outpatient visit in the years 2001 and 2002 when compared with 2000; 
Hispanics were 23.935 times more likely to have an outpatient visit in 2001 
(p=0.001) and 40.859 times more likely to have an outpatient visit in 2002 
(p=0.001). Caucasians did not have an increased overall rate of outpatient use, 
although amongst users the increased rate of outpatient use nears significance in 
year 2001 when compared to 2000. 
Emergency Department Utilization 
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Key findings from the multivariate analysis of emergency department 
utilization are presented in Tables 12 through 14. 
The multivariate analysis confirmed that overall emergency department 
use increased from year 2000. The rate of emergency department use was 1.428 
times greater in 2001 than in 2000 (p=0.034) and 1.693 times greater in 2002 than 
in 2000 (p=0.001) when adjusted for age, gender, race, pregnancy and welfare 
status, and controlled for person-months (Table 12). There was no significant 
difference in the risk of having an emergency department visit from year 2000 to 
year 2001. However, participants in year 2002 were 1.439 times more likely to 
have an emergency department visit than participants in year 2000 (p=0.025) 
when adjusted for other variables (Table 13). Among those who have one or 
more emergency department visits, there is no significant change in the rate of 
emergency department use for service users from year 2000 to year 2001 in the 
population as a whole. However, there is a 1.343 increase in the rate of 
emergency department use for this group from year 2000 to year 2002 (p=0.026) 
when adjusted for other variables (Table 14). Therefore, the overall increase in 
emergency department utilization appears to be due to an increase in the number 
of service users as well as an increased rate of use among those with one or more 
emergency department visits. 
The overall rate of emergency department use for African Americans was 
1.831 times greater in 2002 than in 2000 (p=0.001 ). African Americans are 1.591 
times more likely to have an emergency department visit in year 2002 than in year 
2000 (p=0.012). African Americans did have an increased rate of ED use 
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amongst users compared to 2000, although this value is very near significance in 
2002. Therefore, it appears that this increased rate of ED use amongst African 
Americans is likely due to a combination of increased numbers of participants 
using the ED, as well as increased utilization rate among users. 
Caucasians do not have a higher rate of ED use compared to 2000; 
however, this rate nears significance in 2001. Caucasians were 6.384 times more 
likely to have an emergency department visit in 2001 than in year 2000 (p=0.006) 
when adjusted for other variables; however, this increased risk does not continue 
to year 2002. Therefore, any increase in ED rate amongst Caucasians were due to 
increased number of individuals using the ED. 
Although among Hispanics, there is no change in ED rate compared to 
2000, among Hispanics with one or more emergency department visit, the rate of 
emergency department use is 2.857 times greater in year 2001 than year 2000 
(p=O.OOl) when adjusted for other variables. This difference does not continue to 
year 2002. 
Inpatient Utilization 
Inpatient utilization is presented in Tables 15 through 17 and discussed 
below. 
The multivariate analysis confirmed that there is no difference in inpatient 
utilization, either in the rate of use or in the risk of an inpatient visit, from year 
2000. However, participants categorized as other in their race/ethnicity have an 
inpatient utilization rate 4.321 times greater in year 2002 compared to 2000 
(p=0.038), when adjusted for other variables. Those in the other category with 
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one or more inpatient visits also have an inpatient utilization rate 8.926 times 
greater in 2001 (p=0.004) and 17.782 times greater in 2002 (p=O.OOO) when 
compared with the year 2000. This suggests that this race category has an 
increase in the inpatient rate of utilization among those who use the hospital, but 
that there is no difference in the number of individuals using inpatient services. 
Service Utilization Among Races Compared to Caucasians 
In order to evaluate a possible racial disparity, adjusted incidence rate 
ratios ofthe outcomes for each program year of interest compared to the 
Caucasian population are provided in Table 18. 
Some significant disparities can be seen for outpatient utilization. 
Although not significant for all racial categories, minorities have a decreased rate 
of outpatient utilization compared to Caucasians in year 2000. Although there is 
not a significantly decreased rate of outpatient utilization among African 
Americans compared to Caucasians in 2000, the gap between the races become 
significant in years 2001 and 2002. This rate ratio decreases throughout this time 
period, suggesting an increasing gap in service utilization. Hispanics have a 
significantly lower rate of outpatient utilization than Caucasians for all years of 
interest; however, these rate ratios are increasing throughout this time period, 
suggesting a decreasing gap in service utilization. Others only have a 
significantly lower rate during 2001; no pattern in service utilization compared 
with Caucasians can be discerned. 
There is no difference between ED utilization rates between African 
Americans and Caucasians throughout the years of interest. Hispanics, who 
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initially have a non-significant increased rate in ED use, have a lower rate of ED 
use than Caucasians in 2002, suggesting an overall decrease in ED use for 
Hispanics when compared to Caucasians. Others have a lower rate in 2001, but 
again, no pattern is discernable in ED utilization when compared to Caucasians. 
No initial disparity is noted in year 2000 among any racial group. 
No differences are present throughout the years in inpatient utilization, 
with the exception of Others, who have a lower rate of inpatient utilization during 
the year 2000. 
Discussion 
This study set out to answer two overarching questions: 1) has health 
services utilization for pediatric asthmatics in CCNC changed over time? 2) are 
there racial disparities in health services utilization for this group, and has this 
changed over time? Over time, it had been expected that changes would occur in 
emergency department, hospital and outpatient utilization. Ideally, expected 
improved provider practice, care management, and patient education would have 
lead to greater use of ambulatory care and decreased ED and inpatient utilization; 
however, the data only partially conform to these expected changes. 
Overall outpatient utilization, as expected, has increased significantly from 
2000, due to increased numbers of enrollees using ambulatory care. Part of this 
increase can be explained by the fact that enrollment in CCNC requires the 
identification of a primary care physician. This identification process may 
encourage participants to seek regular care. Further, care managers and 
physicians participating in the program are supposed to stress the importance of 
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regular and continuous physician care, especially in the treatment of chronic 
conditions such as asthma. 
Overall, however, the rate of emergency department utilization has also 
increased significantly from 2000, in part due to increased number of participants 
using the emergency department and an increased rate of emergency department 
use among those with one or more ED visit. Although the ED rate in Durham 
County is also increasing during the time period of interest, it clearly does not 
explain the extent of increase among the CCNC pediatric asthmatics. Children 
with asthma may be more likely than the remaining population to visit the 
emergency department; however, this fact alone cannot explain why the rate of 
increase in emergency department use would be ten-fold greater for this 
population. This increased rate cannot be explained by referral of more severe 
cases of asthma into CCNC, since the majority of children with Medicaid in 
Durham County are emolled in CCNC. The most likely explanation is that 
increased ambulatory care has not yet translated into lower emergency department 
use. In other words, it is possible that the increase in outpatient utilization seen 
from 2000, which is hopefully leading to improved asthma treatment, will not 
lead to a decrease in emergency department use immediately. Families and 
caretakers may need time to assimilate new education and care plans before they 
begin behavioral change. However, this still does not explain that the rate of ED 
use is actually increasing for this time period. There is also the possibility that the 
increased amount of ambulatory care does not equate to appropriate, quality 
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outpatient management. It is difficult to judge this without a comparison of ED 
use among non-CCNC children with asthma during this same time period. 
Inpatient utilization did not change over the time period of interest. This 
is paradoxical in light of the increase in emergency department use. If the 
children using the ED had severe asthma attacks that warranted hospital care, one 
would expect the inpatient utilization to also increase. So, the increased ED use 
with non-concurrent increase in hospitalization could be due to non-severe 
emergent cases or patients seeking to use the ED for urgent, outpatient care. In 
other words, it is possible that participants were seeking care for mild asthma that 
should have been adequately controlled through proper outpatient care. However, 
it may also be that the ED has become extremely effective at dealing with severe 
asthmatic episodes. Also, there is the possibility that the emphasis of the program 
on getting care is pushing people to get care, but these services may not be 
adequately managed through the PCP. Again, it also may be that the increase in 
outpatient utilization has not yet led to increased long-term asthma control. 
It had also been expected that if a racial disparity existed for any of these 
outcomes, ideally under the CCNC plan, it would decrease or disappear. Initially, 
there were few disparities amongst the racial groups. Hispanics had a lower rate 
of outpatient use in the year 2000 than Caucasians; although this difference 
decreased throughout the time period of interest, it was still significant in year 
2002. Although Hispanics and African Americans have increased rates of 
outpatient utilization from 2000, while Caucasian outpatient utilization remains 
steady, a disparity remains between these groups in year 2002. While the 
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Hispanics, as expected, have a decrease in the overall disparity, African 
Americans seem to experience an increasing disparity over time. This may be 
partly due to a change in case mix, or due to the fact that increased rate in 
outpatient utilization among African Americans reaches significance, in part, 
because of a larger sample size. 
Unlike previous studies, this study showed a lack of disparity amongst 
racial groups for ED utilization. If anything, some minority groups, specific 
Hispanics and Others, were less likely to visit the ED than Caucasian participants. 
However, this data must be examined with the caveat that case workers made the 
race identification, not the enrollees themselves. Either way, although some of 
the racial groups showed significant changes in ED utilization over time, none of 
these changes led to an increased rate of use when compared with Caucasians. 
This is an especially favorable outcome from a program perspective, as there have 
been racial disparities in ED use in Medicaid programs in the past. It is possible 
that care managers, aware of the documented disparities seen between these racial 
groups and Caucasians, were particularly attentive to encouraging minorities to 
reduce ED use and increase outpatient utilization. Also, it is possible that 
bilingual care managers or interpreters were in greater supply during later years. 
Inpatient use remains stable for all racial groups except those categorized 
as Others. It appears that there is an increased rate of inpatient use among Others 
those with one or more inpatient visit, suggesting that these individuals are 
suffering from severe asthma or a concurrent illness. However, this increased rate 
of inpatient use brings this racial category to par with the other groups. 
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This study is limited by the inability to measure and control for asthma 
severity. It is possible that patients had more severe disease in later program 
years, contributing to the increase in emergency department use. However, it is 
unlikely that controlling for severity would completely eliminate the striking 
increase in emergency department use from 2000 to 2002. In addition, further 
study encompassing more program years is warranted; it is possible that 
emergency department and hospital utilization decrease later. Further, this study 
could not control for seasonal variations in service utilization; one would expect 
that in the care of a respiratory disease such as asthma, season has an important 
role in disease exacerbation. It is also possible some of the racial differences 
result from shifting populations or changes in case worker race identification. 
Also, it is possible that some encounters were missed if patients used out-
of-county-facilities. It is unlikely that enrollees were using primary care services 
out of Durham County, since patients require special permission to obtain a PCP 
that is out of the CCNC network, but patients could have used specialty care 
outside the county or outside of the Duke/Durham Regional and Lincoln systems. 
Enrollees could have used hospital services in a neighboring county, but unless a 
majority of the patients were engaging services elsewhere, it would not have 
greatly altered the results. Finally, there is always the possibility of data entry 
error. Less data entry error would be likely in the Medicaid claims data. Also, 
any out-of-county service use could have been tracked and added to the 
evaluation with Medicaid claims data. 
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Some implications of this paper are discernible. As mentioned above, 
further research is necessary; specifically, similar analyses extended to further 
program years and Medicaid claims data would provide a better understanding of 
program outcomes. Ideally, a concurrent control group of Carolina ACCESS 
participants would have provided more information as to the effectiveness of the 
program. Further, claim information could have provided information on any 
cost-saving benefit of the program. Other outcomes, such as school absenteeism, 
lung function, symptom-free days or patient satisfaction could also be evaluated. 
From a program standpoint, CCNC may be succeeding in its goal of 
increasing patient ambulatory care utilization. However, more needs to be done 
to decrease the emergency department use among enrollees. This increase in ED 
utilization may be due to the fact that Durham County, unlike some of the other 
counties hires only lay-persons to work as care-managers. It is possible that these 
care-managers, unlike social workers and nurses hired by other counties, do not 
have the medical training necessary accurately determine which children need 
intervention or to education patients. It is also possible that program goals and 
initiatives are not being strongly emphasized to CCNC providers, or, providers, 
without routine evaluations, are not committing to the asthma disease initiatives 
provided by the state. Improved family understanding of asthma and a desire to be 
more participatory in disease control may have decreased caretakers' tolerance 
regarding asthma symptoms, driving patients to the ED at the earliest signs and 
symptoms of an attack. Also, it is possible that the PCPs cannot handle the 
increased caseload, driving patients to seek care through the more accessible 
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emergency department. Increased emphasis on program initiatives, and increased 
care-manager disease training would likely help with these problems; however, 
without a more thorough evaluation it is not known if such measures are 
necessary. 
Regardless, the overall trend looks good for enrollee ambulatory care. 
However, it is unconfirmed whether this increased ambulatory care is improving 
outcomes or saving money. Further study with Medicaid claims data will provide 
a more thorough and accurate account of these findings. The next step will be to 
test for the continuation of this upward emergency department trend, and either to 
confirm a later drop in emergency department utilization, or to find ways of 
revamping the program, with the fundamental goal of converting this increased 
enrollee access to ambulatory care into improved patient outcomes. Qualitative 
analyses on physician practices, as well as patient quality-of-life and health 
information, is necessary to determine how, and if, the program is working. 
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Tables and Figures 
Table 1. Participant Characteristics 
Year in Program 
2000 2001 2002 
Characteristic (n=429) (n=552) (n=724) 
Percent Male 
56.81 56.16 52.07 
Mean Age, yrs (±SD)* 6.16 (±4.75) 6.26 (±5.11) 6.96 (±5.66) 
Race,% 
African American 77.86 78.08 77.49 
Caucasian 9.56 9.60 10.50 
Hispanic 7.46 7.79 7.18 
Other 5.13 4.53 4.83 
Mean months in program 5.06 (3.32) 5.28 (3.13) 5.30 (3.26) 
(±SD) 
Percent Enrolled in Welfare* 45.69 47.46 39.50 
Percent Disabled 1.17 2.17 2.35 
Percent Pregnant* 0.47 0.72 2.21 
Primary Care Provider, % 
Duke Family Medicine Center 16.08 17.39 15.61 
Duke Pediatric Outpatient 39.63 42.39 42.68 
Clinic 
Lincoln Community Health 44.29 40.22 41.71 
Center 
*Significant difference across years, p<0.05 
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Table 2. Outpatient Utilization, by Year 
Year 
Outcome 2000 2001 2002 p-value** 
Mean Outpatient visits, 6.44 (9.56) 8.89 (13.44) 8.06 (9.27) 0.0020 
(±SD) 
By Race/Ethnicity: 6.37 (9.78) 8.62 (13.28) 7.63 (8.70) 0.0154 
African American 7.93 (10.57) 11.89 10.78 0.3842 
Caucasian 5.25 (7.06) (18.76) (11.59) 0.1200 
Hispanic 6.45 (7.16) 9.51 (9.62) 8.79 (10.11) 0.6851 
Other 6.20 (5.89) 7.97 (10.66) 
Outpatient, % with 2:1 visit 77.62 88.22 84.81 0.000 
By Race/Ethnicity: 
African American 78.14 87.47 83.78 0.003 
Caucasian 85.37 86.79 81.58 0.705 
Hispanic 59.38 95.35 98.08 0.000*** 
Other 81.82 92.00 88.57 0.631 *** 
Outpatient user rate, 2.77 (3.85) 3.19 (5.52) 3.03 (5.04) 0.4933 
(±SD)* 
By Race/Ethnicity: 2.82 (3.77) 3.34 (5.93) 2.99 (5.19) 0.4151 
African American 2.29 (2.34) 3.33 (4.20) 3.95 (4.77) 0.2032 
Caucasian 3.71 (7.25) 2.50 (4.10) 2.46 (3.94) 0.5837 
Hispanic 1.69 (1.75) 1.59 (1.40) 2.74 (4.93) 0.4088 
Other 
Bolded values are significant 
*Mean rate per active months among participants with ?::1 Outpatient visit 
**Analyses over time: Mean Outpatient visit & Mean user Outpatient rate analyses: one-way AN OVA;% with Outpatient 
visit analyses: chi squared 
***Fisher's Exact 
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Table 3. Emergency Department Utilization, by Year 
Year 
Outcome 2000 2001 2002 p-value** 
Mean ED visits, (±SD) 0.23 (0.60) 0.34 (0.86) 0.44 (1.10) 0.0005 
By Race/Ethnicity: 
African American 0.22 (0.58) 0.32 (0.82) 0.46 (1.14) 0.0006 
Caucasian 0.17 (0.63) 0.60 (1.13) 0.49 (1.14) 0.1235 
Hispanic 0.25 (0.51) 0.40 (0.98) 0.19 (0.56) 0.3850 
Other 0.45 (0.91) 0.12 (0.33) 0.51 (1.04) 0.1897 
ED, % with 2:1 visit 15.85 20.83 23.07 0.013 
By Race/Ethnicity: 
African American 15.27 19.95 23.53 0.012 
Caucasian 7.32 33.96 25.00 0.010 
Hispanic 21.88 18.60 13.46 0.590 
Other 31.82 12.00 25.71 0.283*** 
ED user rate, (±SD)* 0.36 (0.33) 0.52 (0.66) 0.54 (0.59) 0.0820 
By Race/Ethnicity: 
African American 0.40 (0.35) 0.50 (0.67) 0.58 (0.63) 0.1952 
Caucasian 0.50 (0.43) 0.56 (0.68) 0.38 (0.27) 0.5771 
Hispanic 0.17 (0.09) 0.79 (0.66) 0.40 (0.34) 0.0424 
Other 0.22 (0.13) 0.19 (0.06) 0.54 (0.70) 0.3805 
Bolded values are significant 
*Mean rate per active months among participants with ::::r ED visit 
**Analyses over time: Mean ED visit & Mean user ED rate analyses: one-way AN OVA;% with ED visit analyses: chi 
squared 
***Fisher's Exact 
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Table 5. Inpatient Utilization, by Year 
Year 
Outcome 2000 2001 2002 p-value** 
Mean Inpatient visits, (±SD) 0.94 (2.77) 1.05 (3.56) 1.12 (3.01) 0.6407 
By Race/Ethnicity: 
African American 0.98 (2.99) 1.07 (3.58) 1.07 (2.85) 0.9110 
Caucasian 0.93 (2.04) 0.79 (1.97) 1.57 (3.83) 0.2912 
Hispanic 0.97 (2.04) 1.28 (5.39) 0.87 (1.95) 0.8451 
Other 0.23 (0.43) 0.92 (1.61) 1.29 (4.47) 0.4511 
Inpatient, %with ::>1 visit 23.90 22.28 23.48 0.712 
By Race/Ethnicity: 
African American 19.76 21.81 22.64 0.597 
Caucasian 29.27 24.53 28.95 0.829 
Hispanic 28.13 20.93 25.00 0.767 
Other 22.73 28.00 22.86 0.881 
Inpatient user rate, (±SD)* 1.31 (1.45) 1.51 (2.28) 1.79 (2.74) 0.2629 
By Race/Ethnicity: 
African American 1.55 (1.58) 1.73 (2.54) 1.68 (2.20) 0.8802 
Caucasian 0.86 (0.84) 0.95 (0.78) 2.60 (4.53) 0.2037 
Hispanic 0.69 (0.91) 0.73 (1.02) 1.21 (2.38) 0.7310 
Other 0.25 (0.15) 0.71 (0.38) 2.19 (4.41) 0.4376 
Bolded values are significant 
*Mean rate per active months among participants with~ 1 Inpatient visit 
**Analyses over time: Mean Inpatient visit & Mean user Inpatient rate analyses: one-way ANOVA;% with Inpatient visit 
analyses: chi squared 
31 






Bolded values are significant 
*One-way ANOV A across races 
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Table 9. Adjusted* Rate Risk of Outpatient Utilization 
Outpatient Use 
Year Incidence Rate Ratio* p-value 
2001, overall 1.317 0.007 
By Race/Ethnicity 
African American 1.249 0.068 
Caucasian 1.592 0.102 
Hispanic 1.789 0.060 
Other 0.953 0.884 
2002, overall 1.216 0.032 
By Race/Ethnicity 
African American 1.148 0.191 
Caucasian 1.232 0.363 
Hispanic 2.033 0.016 
Other 1.334 0.374 
Bolded values are significant 
*Poisson Regression; Reference year 2000, adjusted for age, gender, race, pregnancy and welfare status, offset by log of active 
months 
Table 10. Adjusted* Risk of Outpatient Visit 
Outpatient Use 
Year Odds Ratio* p-value 
2001, overall 2.386 0.000 
By Race/Ethnicity 
African American 2.125 0.000 
Caucasian 1.174 0.794 
Hispanic 23.935 0.001 
Other 2.233 0.406 
2002, overall 1.439 0.025 
By Race/Ethnicity 
African American 1.769 0.002 
Caucasian 0.748 0.597 
Hispanic 40.859 0.001 
Other 1.300 0.746 
Bolded values are significant 
*Logistic Regression; Reference year 2000, adjusted for age, gender, race, pregnancy and welfare status, active months 
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Table 11. Adjusted* Rate Risk of Outpatient Utilization Among Outpatient Users 
Outpatient User 
Year Incidence Rate Ratio* p-value 
2001, overall 1.161 0.138 
By Race/Ethnicity 
African American 1.127 0.314 
Caucasian 1.590 0.082 
Hispanic 1.029 0.924 
Other 0.846 0.582 
2002, overall 1.108 0.245 
By Race/Ethnicity 
African American 1.062 0.559 
Caucasian 1.300 0.208 
Hispanic 1.181 0.538 
Other 1.287 0.423 
Bolded values are significant 
*Poisson Regression; Reference year 2000, adjusted for age, gender, race, pregnancy and welfare status, offset by log of 
active months 
[Among those subjects with ?: 1 outpatient visits] 
Table 12. Adjusted* Rate Risk of Emergency Department Utilization 
Emergency Department Use 
Year Incidence Rate Ratio* p-value 
2001, overall 1.428 0.034 
By Race/Ethnicity 
African American 1.409 0.078 
Caucasian 3.116 0.066 
Hispanic 1.572 0.383 
Other 0.324 0.090 
2002, overall 1.693 0.001 
By Race/Ethnicity 
African American 1.831 0.001 
Caucasian 2.516 0.134 
Hispanic 0.603 0.424 
Other 1.117 0.852 
Bolded values are significant 
*Poisson Regression; Reference year 2000, adjusted for age, gender, race, pregnancy and welfare status, offset by log of 
active months 
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Table 13. Adjusted* Risk of Emergency Department Visit 
Emergency Department Use 
Year Odds Ratio* p-value 
200 I, overall 1.381 0.059 
By Race/Ethnicity 
African American 1.388 0.095 
Caucasian 6.384 0.006 
Hispanic 0.846 0.783 
Other 0.289 0.137 
2002, overall 1.439 0.025 
By Race/Ethnicity 
African American 1.591 0.012 
Caucasian 3.533 0.061 
Hispanic 0.569 0.401 
Other 0.616 0.470 
Bolded values are significant 
*Logistic Regression; Reference year 2000, adjusted for age, gender, race, pregnancy and welfare status, active months 
Table 14. Adjusted* Rate Risk of Emergency Department Utilization Among Emergency 
Department Users 
Emergency Department 
Year User p-value 
Incidence Rate Ratio* 
200 I, overall 1.233 0.106 
By Race/Ethnicity 
African American 1.141 0.362 
Caucasian 1.171 0.628 
Hispanic 2.857 0.001 
Other 1.313 0.606 
2002, overall 1.343 0.026 
By Race/Ethnicity 
African American 1.348 0.053 
Caucasian 1.085 0.799 
Hispanic 1.286 0.589 
Other 1.567 0.328 
Bolded values are significant 
*Poisson Regression; Reference year 2000, adjusted for age, gender, race, pregnancy and welfare status, offset by log of 
active months 
[Among those subjects with ?:I emergency department visits] 
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Table 15. Adjusted* Rate Risk of Inpatient Utilization 
Inpatient Use 
Year Incidence Rate Ratio* p-value 
2001, overall 1.076 0.719 
By Race/Ethnicity 
African American 1.031 0.898 
Caucasian 0.834 0.702 
Hispanic 1.300 0.680 
Other 3.492 0.082 
2002, overall 1.086 0.719 
By Race/Ethnicity 
African American 1.013 0.949 
Caucasian 1.129 0.771 
Hispanic 0.844 0.766 
Other 4.321 O.o38 
Bolded values are significant 
*Poisson Regression; Reference year 2000, adjusted for age, gender, race, pregnancy and welfare status, offset by log of 
active months 
Table 16. Adjusted* Risk oflnpatient Visit 
Inpatient Use 
Year Odds Ratio* p-value 
2001, overall 1.051 0.754 
By Race/Ethnicity 
African American 1.143 0.465 
Caucasian 0.758 0.568 
Hispanic 0.634 0.436 
Other 1.203 0.804 
2002, overall 1.049 0.749 
By Race/Ethnicity 
African American 1.159 0.398 
Caucasian 0.770 0.560 
Hispanic 0.779 0.672 
Other 0.481 0.344 
Bolded values are significant 
*Logistic Regression; Reference year 2000, adjusted for age, gender, race, pregnancy and welfare status, active months 
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Table 17. Adjusted* Rate Risk oflnpatient Utilization Among Inpatient Users 
Inpatient User 
Year Incidence Rate Ratio* p-value 
2001, overall 1.108 0.544 
By Race/Ethnicity 
African American 0.983 0.930 
Caucasian 1.353 0.491 
Hispanic 2.214 0.252 
Other 8.926 0.004 
2002, overall 1.064 0.672 
By Race/Ethnicity 
African American 0.894 0.491 
Caucasian 1.849 0.096 
Hispanic 1.681 0.193 
Other 17.782 0.000 
Bolded values are significant 
*Poisson Regression; Reference year 2000, adjusted for age, gender, race, pregnancy and weltftre status, offset by log of 
active months 
[Among those subjects with ::0:1 inpatient visits] 
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Table 18. Outcome Utilization Rates by Race Compared to Caucasians, by Year 

















































*Poisson Regression; Reference race Caucasian, adjusted for age, gender, race, pregnancy and welfare status, offset by log 
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Figure 1. Mean Outcome Visits, by Year 
3 
--+- Mean Outpatient 
Visits 
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Mean ED Visits 
Mean outpatient, inpatient and emergency department visits have an overall increasing trend from 
year 2000 to year 2002. 
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Pediatric Asthma: Burden of Suffering 
Overview 
The most common chronic disease of childhood, asthma is responsible for 
a large percentage of urgent care visits and hospitalizations each year. Asthma 
management can be complex, sometimes requiring multiple medications and 
excellent patient and provider communication. However, mismanaged asthma 
can be costly, adding to the disease's already high economic and personal burden. 
Asthma: Diagnosis, Management and Prognosis 
Asthma is characterized by reversible obstruction of large and small 
airways in the lungs due to a hyperreactivity to various triggers. Typified by 
intermittent and recurrent episodes of cough, shortness of breath and wheezing, 
this chronic disease is classified and treated based on symptom severity (Table 1 ). 
Bronchial hyperreactivity, the central feature of asthma, is due to an 
allergic inflammatory response to an environmental stimulus. As bronchial 
inflammation increases, mucosal edema, smooth muscle contraction and mucus 
production lead to airway obstruction. This obstruction causes the wheezing 
attacks and other symptoms of asthma. All young children and infants, with their 
smaller airway size, lower elastic recoil, decreased smooth muscle supports, 
mucous gland hyperplasia and decreased collateral ventilation are at increased 
risk for airway obstruction. Symptoms of asthma can be initiated by various 
triggers, including allergens, viral infections, and exercise. 1 
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Table 1. Asthma Classification and Treatment 
Asthma Symptom Severity 
Severity 
Classification 
Mild Intermittent • Symptoms 5.2 times a 
week 
• Asymptomatic & Normal 
PEF between exacerbations 
• Nighttime symptoms 5.2 
times a month 
Mild Persistent • Symptoms 2:2 times a 
week but 5.2 times a day 
• Exacerbations may affect 
activity 
• Nighttime symptoms 2: 2 
times a month 
Moderate Persistent • Daily symptoms 
• Daily use of inhaled 
short-acting beta2-agonists 
• Exacerbation affects 
activities 
• Nighttime symptoms >I 
time a week 
Severe Persistent • Continual symptoms 
• Limited physical activity 
• Frequent exacerbations 
• Frequent nighttime 
symptoms 
*FEVs forced exp1ratory volume at I second 
tPEF =peak expiratory flow 
Source: Institute for Clinical Systems Improvemene 
Lung Long-Term 
Function Control Daily 
Medications 
FEY 1* or PEFt No daily medications 




FEV1 orPEF Low dose inhaled 
2:80% predicted corticosteroids 
andPEF (preferred) 
variability 20- OR 
30% leukotriene modifiers, 
theophylline, 
nedocromil or cromolyn 
FEV1 orPEF Medium or high dose 
2:60% - S:80% inhaled corticosteroid 
predicted and plus inhaled long-acting 
PEF variability beta2-agonist (preferred) 
2:30% OR 
Medium dose inhaled 
corticosteroid plus 
leukotriene modifier, 
theophylline or oral 
long-acting beta,-
agonist 
FEV1 orPEF Medium or high dose 
S:60% predicted inhaled corticosteroid 
and PEF PLUS long-acting beta,-
variability agonist (preferred) 
2:30% AND/OR leukotriene 
modifier 
AND/OR theophylline 
The National Lung, Heart and Blood Institute (NLHBI), in their Expert 
Panel Report on the diagnosis and management of asthma, based their 
recommendations for care around four components of asthma management: 1) 
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objective measures and assessment of asthma monitoring 2) control of factors 
contributing to asthma severity, 3) pharmacologic therapy, and 4) patient 
education for a partnership in asthma management.3 
Measurement and assessment of asthma monitoring is two-part, including 
the initial diagnosis and assessment of asthma and the periodic assessment and 
monitoring of the patient. The initial diagnosis is established when the clinician 
finds episodic symptoms of partially reversible airflow obstruction, such as 
wheezing and shortness of breath and other diagnoses, such as infections, 
pulmonary malformations or cystic fibrosis are excluded. Asthma severity, based 
on symptom severity, nighttime symptoms and lung function, is assessed as either 
mild intermittent, mild persistent, moderate persistent or severe persistent (Table 
I). After the initial diagnosis and assessment are made, periodic monitoring and 
reassessment are required to determine effectiveness of asthma therapy. The 
NLHBI recommends discussing quality of life, asthma signs and symptoms, 
number and type of asthma exacerbations and medications at these clinic visits. 
Such activities are done with the goal of maintaining as near normal lung function 
as possible while preventing chronic symptoms and exacerbations. 
Control of environmental factors, such as cigarette smoke, particulate 
matter pollution and allergens can reduce asthma exacerbations. Other 
contributing factors include gastroesophageal reflux (GER), rhinitis, sinuisitis and 
allergic bronchopulmonary aspergillosis, all of which can trigger severe asthma 
symptoms. Further, viral infections and even cold air can increase asthma 
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severity. Discussion of these factors with the patient, as well as attempts to 
control or remove them, are important for proper asthma management. 
Pharmacotherapy is necessary to reverse and decrease the frequency of 
asthmatic symptoms (Table 1 ). Such management is obtained by use of selective 
betaz-agonists, or bronchodilators, which relax broncholary smooth muscle, as 
well as increase mucociliary clearance. Short -acting beta2-agonists, such as 
albuterol, are useful for acute attacks or quick-relieftherapy in chronic asthma. 
Long-acting beta2-agonists, such sahneterol, last approximately 12 hours and are 
useful in treating chronic asthma that is not responsive to other therapy. Chronic 
asthma (mild persistent, moderate persistent, or severe persistent) also requires 
anti-inflammatory medication for prevention of symptoms. These medicines 
include mast cell degranulation inhibitors ( cromolyn, nedocromil), inhaled 
corticosteroids (fluticasone) and oral corticosteroids. Oral corticosteroids have a 
host of deleterious side effects and are only used for chronic disease if all other 
therapies fail. Other anti-inflammatory agents include leukotriene antagonists and 
lipoxygenase inhibitors, as well as sustained-released preparations of 
theophylline, which is a bronchodilator with mild anti-inflammatory effects. 
As patient understanding and adherence are necessary for proper asthma 
management, it is important that asthma education and self-management 
techniques are stressed from the first visit. Open communication to encourage 
compliance, as well as a tailored, written action plan, should be provided to each 
patient. 
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The long-term prognosis for asthma is good; however, patients may 
require emergency treatment or hospitalization for asthma control. Although 
asthma can be fatal, the majority of patients diagnosed before age five are free of 
symptoms by adolescence. Those at increased risk for persistent asthma include 
those with severe asthma, specific allergies, a family history of asthma, lower 
respiratory tract infection in infancy and maternal smoking. 1•2.3 
Pediatric Asthma Morbidity and Mortality: A Population Perspective 
Asthma affects over 14.9 million people in the United States; a 
disproportionate percentage of those affected are children. According to the 
National Center for Health Statistics, approximately 8.9 million children have had 
a diagnosis of asthma and approximately 4.2 million children have had an asthma 
attack in the past year, making asthma the most common chronic disease of 
childhood (Table 2). Further, in 1995 asthma was responsible for 1.5 million 
emergency department visits, over 500,000 hospitalizations and 5,500 deaths.4 In 
1998, asthma management accounted for approximately 12.7 billion dollars in 
health care costs5 and has increased to over 14 billion dollars in 20046 The 
personal and economic burden of asthma is high, especially for children. 
Asthma prevalence and sequelae differs among various age groups (Table 
2). Over 12% of children (under 18 years old) have had a diagnosis of asthma at 
some point in their lives, with 5. 7% having an asthma attack in the past 12 
months. Children are also more likely than adults to have a hospital stay due to 
asthma, with a rate of27.5 per 10,000. However, children are less likely than 
adults to die from asthma, with a mortality rate of 0.3 per 100,000. It is important 
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to note that there are differences among pediatric age groups as well; children 
aged 0-4 years old, while having a lower prevalence of asthma than all children 
(7.0%), are responsible for the most asthma hospitalizations, with a rate of 60.3 
per 10,0007 
Table 2. Asthma Prevalence by Age 
Age Range, Lifetime Asthma Asthma Asthma 
years Asthma Attack Hospital Mortality 
Diagnosis Prevalence, 0/o Discharge Rate, 
Prevalence, 0/o Rate, Per 100,000 
Per 10,000 
All (0-65+) 10.8 4.2 16.5 1.5 
0-17 12.4 5.7 27.5 0.3 
0-4 7.7 4.6 60.3 0.2 
5-17 14.1 6.1 15.6 0.3 
18+ 10.3 3.7 12.7 2.0 
Source. Natwnal Center for Health Stat1sttcs 
Boys were more likely than girls to have been diagnosed with asthma 
(14% versus 10%) and more likely to have had an attack in the past 12 months 
(7% versus 5%). Other risk factors for a diagnosis of asthma included low 
socioeconomic status, belonging to a single-mother family, or being African 
American. Children who were in poor or fair health were seven times more likely 
to have had an asthma attack in the past year than those in good or excellent 
health8 
Pediatric asthma prevalence has changed over time, with an average 
increase of 4.3% per year from 1980 to 1996, and a peak prevalence of7.5% in 
1995. The asthma hospitalization rate increased as well from 1980 to 1999, by 
1.4% per year. More concerning, the pediatric asthma death rate increased by 
3.4% per year from 1980 to 1998.9 
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Economic Burden of Asthma 
With such a high morbidity, it is not surprising that asthma also has a high 
economic burden. According to a study by the American Lung Association, 
direct and indirect costs of adult and pediatric asthma totaled approximately 14 
billion dollars in 2004. The majority of this cost was associated with direct costs, 
such as hospitalization and medications; however, indirect costs, such as missed 
school days, were one-third of the total expenditure (Figure 1 )6 
Figure 1. Economic Costs of Asthma 
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Several studies of pediatric asthma have estimated asthma-related costs. 
Using the 1987 National Medical Expenditure Survey, Lozano and associates 
assessed the per capita impact of pediatric asthma on medical care utilization and 
total expenditures. Using the responses of all children aged 1-17 years old with 
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(n=667) and without (n = 6911) asthma, the authors reported that children with 
asthma incurred an average of $1,129 (SD $531 0) per child per year in total 
health care expenditures compared with $468 (SD $2960) for children without 
asthma. However, 84.9% of health expenditures of children with asthma were 
due to non-asthma care. Specifically, the authors reported that the mean asthma-
related per capita expenditures totaled $171 (SD $779) per year for asthmatic 
children. 
This expense can be broken down by service (Figure 2); the majority of 
expense resulted from asthma-related hospitalizations. Specifically, the authors 
totaled the individual costs at $34 (SD $1 00) for asthma prescriptions, $31 (SD 
$138) for ambulatory visits for asthma, $18 (SD $119) for asthma ED visits, and 
$87 (SD $701) for asthma hospitalizations. Also of note, children with asthma 
had significantly higher rates of health care utilization, including 3.1 times as 
many prescriptions, 1.9 times as many ambulatory provider visits, 2.2 times as 
many emergency department visits, and 3.5 times as many hospitalizations as 
compared with children without asthma. 10 
Lozano and associates, in a population-based historical cohort study of 
children (n=71818) also attempted to determine the impact of asthma on the use 
and cost of health care by children in a managed care organization. Children with 
asthma (n=3531) incurred $1060.32 per year in health care costs, compared with 
costs of$563.81 per year incurred by non-asthmatic children. Two-thirds of the 
costs incurred by the asthmatic children were due to non-urgent care and 
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medications, with the remaining percentage due to hospitalizations and urgent 
care. These figures differ from Lozano et al's earlier study, in which over half of 
the direct costs of pediatric asthma were due to hospitalizations. This may be due 
to recall bias in the parental surveys, or due to the differing populations, as the 
initial study included children in a variety of health plans as well as the uninsured. 
In addition, Lozano and associated found that children with asthma in a 
managed care organization filled 2.77 times as many prescriptions (11.59 vs 
4.19/yr), made 65% more non-urgent outpatient visits (5.75 vs 3.48/yr), and had 
twice as many inpatient days (.23 vs .11/yr) compared to children without the 
diagnosis, which is comparable to their early study. When the authors controlled 
for age, sex, and comorbidities, they determined the marginal cost of asthma 
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totaled at $615.17/yr (95% confidence interval $502.73, $727.61), including both 
asthma and non-asthma related services. 11 
A smaller study conducted in 2003 of a total of 63 8 children with mild to 
moderate asthma enrolled in managed care organizations reported a medial total 
annual asthma-related cost of $564 (interquartile range (IQR), $131 to $1602). 
This study included both indirect and direct costs of asthma, with indirect costs 
accounting for 54.6% of total costs. Direct costs were also tallied; the median 
direct asthma related cost was $378 (IQR, $114 to $808) and the median annual 
medication cost was totaled at $109 (IQR, $6 to $512). 12 
It appears that patient-level costs for pediatric asthma-vary by population 
and study technique. Irregardless, a high level of economic burden results from 
asthma each year, besides some of the immeasurable tolls on child and family 
quality oflife. From the inconvenience of taking multiple medications, the 
limitations on family activities and the stress of hospitalization and acute care, 
asthma places a heavy burden on the children and family it affects. 
In summary, asthma is disease that is highly prevalent among children. 
Although the long-term prognosis is good for this disease, proper management 
with medications, education and environmental controls are necessary to reduce 
morbidity and mortality. Childhood asthma also has a high economic burden, 
although difficulty measuring indirect costs and possible biases measuring direct 
costs limit the ability to properly assess this burden. 
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ADDENDUMB 
Effect of Pediatric Case Management on 
Emergency Department and Hospital Utilization 
Introduction 
Affecting 8.9 million children in United States, asthma is the leading 
cause of chronic illness in the pediatric population. 1 Asthma caused 14.6 million 
lost school days in 20022 and over 650,000 pediatric emergency room visits in 
1999,3 and ranked as the third most common cause of hospitalization for children 
under 15 in 20044 Asthma was responsible for approximately 14 billion dollars 
in healthcare costs in 2004,2 with the single largest indirect cost due to lost 
productivity related to school absence.5 
In a response to the heavy financial burden of asthma care, insurance 
companies began to embrace case management as a way to improve quality of 
care and decrease the heavy burden of costs associated with asthma. 6 Case 
management is defined by the Case Management Society of America (CMSA) as 
"a collaborative process of assessment, planning, facilitation and advocacy for 
options and services to meet an individual's health needs through communication 
and available resources to promote quality cost-effective outcomes."7 In the 
instance of asthma, case management identifies high risk or high utilization 
patients and then implements individualized care plans in an attempt to improve 
patient quality of life while minimizing use of quick-fix, high-cost treatments, 
specifically hospital and emergency department visits. 
With over 82% of U.S. insurance plans offering some type of asthma case 
management in 2004, the health insurance industry has seemed to embraced case 
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management as a successful way to improve the health of patients with asthma, as 
well as reduce hospital and emergency department use.8 However, there has been 
no systematic review of the limited literature regarding asthma case management 
in the pediatric population. This systematic review attempts to determine the 
effectiveness of asthma case management on reducing hospital and emergency 
department use in the pediatric population. 
Methods 
Literature Search 
I searched the Cochrane Library and MEDLINE using the search terms 
"childhood asthma" OR "asthma" AND "case management," searching either as 
the Medical Subject Heading or as key words. The search was not delimited. The 
references from relevant articles were also hand searched. 
Study Selection 
I screened the title and abstract of all citations found through the search 
approach. Full-text articles were obtained for all potentially eligible or relevant 
studies. 
Randomized controlled trials of at least one year duration with at least 50 
participants were considered eligible if they fulfilled the following criteria: 
included children aged 0-18 with asthma; used a case-management approach or 
intervention to improve management or symptoms of asthma; reported one or 
more of the outcomes of interest, which were emergency department (ED) use or 
hospitalizations. Studies were excluded if they lacked randomization or a 
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concurrent control group, included adults, did not employ a case-management 
approach that included patient care or lacked the outcomes of interest. 
Study Quality Assessment 
Study quality was assessed on internal and external validity of the trial. 
Internal validity, rated as good, fair or poor, was based on the criteria created by 
the US Preventive Services Task Force. 9 Internal validity rating was judged on 
allocation concealment, intention-to-treat, similarity of compared groups at 
baseline and systematic differences between compared groups in withdrawals or 
loss-to-follow-up. No study was blinded and, due to the impossibility of blinding 
with a case management approach, studies were not down-graded for lack of 
patient blinding. External validity, also rated as good, fair or poor, was based 
upon assessment of the study's generalizability. 
Quantitative Data Extraction 
Some of the studies reported the outcomes of interest with different scales 
or did not provide a p-value for the outcome. If possible, data was extracted from 
the study to provide a consistent scale. P-values were calculated using 
appropriate bivariate analyses if measures of variance or raw data were provided 
within the study. Specifically, 2-sample t-tests and chi-squared analyses were 
performed using the program STAT A. 
Results 
Of the 72 non-duplicated abstracts identified through the search 
strategy, 22 were potentially eligible. Nineteen were determined to be ineligible, 
due to lack of randomization or concurrent control group (n= 16), inclusion of 
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adults (n= 1 ), lacking the outcomes of interest (n=1) or the utilization of an audit 
facilitator who reviewed charts, provided information and equipment, but had no 
patient or physician contact, which was deemed not to be consistent with case-
management (n=1). Therefore, a total of3 studies were considered eligible 
(Figure 1). ~>:: ;:M;~:d!:i.\i~.ari~:.t;~-~~ii-~~t~b~e-
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Figure 1. Abstract search flow diagram. 
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Study characteristics are summarized in tables 1 and 2 and described 
below. 
Hughes and associates studied patients aged 6-16 admitted to the Izaak 
Walton Killam Children's Hospital in Halifax county, Nova Scotia with the 
diagnosis of asthma. Case management interventions included 3-month clinic 
visits, education and home visits by a research nurse. 10 
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3-month clinic visits, education & 
home visits by a specially trained 
research nurse 
Intervention delivered by masters-
level social worker referred to as 
Asthma Counselor (AC) who met 
with caretakers to improve 
communication between family and 
physician. 











Asthma severity,% symptom 
free days/nights, 
clinic/office/ED visits, 
hospital admissions, PFTs, 
school absenteeism, metered 
aerosol technique, 
educational questionnaire 
score, care satisfaction, 
patient responsibility 




ED use, hospitalizations, cost 
per patient(% reduction, 
compared with baseline year) 
Evans and associates studied patients aged 5-11 identified either through 
the emergency department or primary care clinics and meeting at least one of the 
following asthma severity criteria: I) use of two or more asthma meds, 2) greater 
than one asthma hospitalization, 3) one or more unscheduled visits for asthma OR 
two weeks before recruitment had respiratory symptoms more than two days or 
sleep disruption more than two nights. The care management intervention was 
delivered by a masters-level social worker referred to as Asthma Counselor (AC) 
who met with caretakers to improve communication between family and 
physician. Primary care physicians were sent blank asthma care plans, spacers, 
peak-flow monitors and the NHLBI asthma guidelines by the AC. Caretakers 
education sessions, and pillow and mattress covers were also provided. At 
minimum, each study family met with AC every two months and spoke with AC 
on telephone every other month. 11 
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Table 2. Study participant characteristics 
Author, Year Participants, Participant 
(reference) n Age Range, 
years 
Hughes eta\, 1991 95 6-16 
(10) 
Evans et al, 1999 1033 5-11 
(II) 




Admitted to Izaak Walton Killam Children's 
Hospital in Halifax county, Nova Scotia with 
diagnosis of asthma in preceding 5 years 
Identified through ED or primary care clinic, filling 
at least 1 severity criteria 6 months before 
recruitment 
Recruited by reviewing hospitalization lists for 
patients admitted with the diagnosis of acute asthma 
OR referred by PCP 
Greineder and associates studied patients aged 1-15 who were identified 
either by reviewing hospitalization lists for a diagnosis of acute asthma with or 
without status asthmaticus or by primary care physician referral based on the 
subjective impression that the patient was at increased risk of exacerbation. The 
case management intervention consisted of intensive asthma education and an 
asthma outreach program (AOP). The AOP was implemented by an experienced 
allergy nurse, a nurse practitioner, and an allergist who provided individualized 
asthma plans, care, referrals and follow-up phone calls. The control group also 
received the asthma education, but no other care management activities. 12 
Study Quality 
Study quality assessments are summarized in table 3 and described below. 
The internal validity of the study by Hughes and associates was somewhat 
compromised by a lack of discussion of allocation concealment and a significant 
gender difference across groups despite randomization. Further, no power 
calculations were provided and it is likely, due to the small number of 
participants, that this study did not have adequate power to determine differences 
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between the study and control groups for the outcomes of interest. External 
validity was limited by the use of a small, specific Canadian population. 
Therefore, both external and internal validity were given a score of fair. This 
study was supported by a grant from the Hospital for Sick Children Foundation, 
Toronto, Ontario, Canada. 
The study by Evans and associates provided good internal validity, with 
adequate allocation concealment and similar baseline characteristics of control 
and study groups. This study had a power of 90% to detect a difference of 25% in 
the mean number of symptom days between groups; however, no power 
calculation was performed for the outcomes of interest. As the study consisted of 
participants from eight urban centers throughout the country, the external validity 
was considered good. The National Cooperative Inner-City Asthma Study was a 
collaboration of various institutions and investigators; Key Pharmaceuticals, 
Monaghan Medical Corporation and Allergy Control Products donated some of 
the equipment. 
There was some minor concern for the author over the internal validity of 
the study by Greineder and associates. Patients were enrolled either through 
hospitalization records or by their PCP if considered "high risk." Depending on 
the process of physician-based patient recruitment, which was not discussed in the 
paper, it is possible that there was some selection bias in this process. 
Specifically, there may be concern that certain physicians consistently referred 
healthier or sicker patients than their colleagues, or those recruited from the 
hospital. The authors attempted to control this situation with a stratified 
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randomization scheme, ensuring equal numbers of hospital and PCP-recruited 
patients in each group. No information on allocation concealment was discussed. 
Also, no power calculations were provided and, due to the small number of 
participants, it is likely the study did not have the power to detect a difference in 
the outcomes of interest. As the study included participants from a variety of 
urban health centers, the external validity was deemed good. This study was 
supported in part by the Harvard Pilgrim Health Care Foundation. 




Hughesetal, 1991 (10) 
Evansetal, 1999(11) 









Unsure of allocation 
concealment, gender differences 
despite randomization, small 
numbers/ 
Low power, possible recall bias on 
some outcomes, no blinding 
Good 
Possible recall bias on some 








Inner city children in area 
with at least 20% of 
population below FPL, 
various urban centers 
Good 
Possible selection bias as HMO insured children 
patients were enrolled either from urban health centers 
through hospitalization lists or by 
?CPs if considered "high risk" 
(attempted to control with paired 
randomization), unsure of 
allocation concealment, no 
blinding, small numbers/low 
power. 
*Based on US Preventive Task Force Serv1ce Cntena (9) 
I did not conduct a meta-analysis as two of the three papers did not have 
adequate power to detect a difference in the outcomes of interest. Also, there 
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were significant differences in the participant ages and characteristics. With only 
three papers, there would likely be a publication bias, as well. 
Emergency Department Use 
All three studies reported emergency department use as an outcome (Table 
4). Each study demonstrated a downward trend in emergency department use in 
the intervention versus the control groups; however, no study could show a 
significant difference in mean number emergency department visits between 
control and intervention groups. It is important to note that the study by Evans 
and associates included urgent care visits as well as emergency department use, 
leading to the higher mean number of visits when compared with the other 
studies. 
Table 4. Emergency department use 
Study 
Author, year (reference) 
Hughes eta!, 1991 (10), year 1 
year 2 
Evans eta!, 1999(11), year 1 
year 2 
Greineder et al, 1999 (12), year 1 
NR-Not Reported and unable to calculate 
*Pearson's chi squared 
Hospitalization 



















All three studies reported hospitalization as an outcome (Table 5). Evans 
and associates showed non-significant decreases in hospitalizations for the 
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intervention group year one and year two when compared to control. Greineder 
and associates, however, had non-significant increases in hospitalization for both 
years in the intervention group when compared to control. Hughes and associates 
also showed a non-significant increase for this outcome in the intervention group 
compared with control during year one of their study. 
Table 5. Percent patients hospitalized 
%Participants Hospitalized (#/n) 
Study 
Author, year (reference) Control Intervention p-value 
Hughes eta!, I99I (IO), year I I8.8 (9/48) 31.9 (I5/47) 0. I40* 
year2 I2.5 (6/48) I2.8 (6/47) 0.969* 
Evans et a!, I 999 (I I), year I I 8.9 (98/5 I 8) I4.8 (76/515) 0.071 
year 2 I3.8 10.20 0.078 
Greineder et a1, I999 (12), year 1 28.6 (8/28) 10.3 (3/29) 0.1 03t 
*Pearson's chi squared 
tFisher's exact test control 
Other Reported Outcomes 
Hughes and associates reported that study subjects had less school 
absenteeism (10.7 vs. 16.0 days, p=0.04) than control from the baseline year 
before the study. The study group, despite similar baseline lung function as the 
control group at baseline, had significantly better small airway function 
(p=O.OOOI) at the one year point than the control. Also, the study group 
demonstrated significantly better metered aerosol technique (p=0.0005) than 
control subjects at the one year point. Both groups were similar at baseline. 
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Evans and associates reported that, averaged over the first twelve months, 
the intervention group had significantly fewer symptom days in the two weeks 
before each follow-up interview (3.51 vs. 4.06 days, a difference of0.55, 95% CI, 
0.18 to 0.92). 
Greineder and associates estimated health care costs by extracting data 
related to a range of asthma-related diagnoses from a claims computer. The 
authors found that using the AOP resulted in the direct savings to the health plan 
ranging from $7.69 to $11.69 for every dollar spent on the AOP nurse's salary. 
Discussion 
Pediatric asthma case management resulted in a small, non-significant 
decrease in emergency department use for all three studies and a small, non-
significant decrease in percentage of patients hospitalized in two studies. 
However, this lack of significant findings needs to be interpreted with caution, as 
two of the studies clearly did not have the power to determine significance for the 
selected outcomes. Also, these results need to be placed in context with other 
evidence regarding case management, including the importance of case 
management in improving patient care and function, as well as decreasing the 
high cost of asthma care. 
Other studies not included in the systematic review, due to lack of 
randomization or a concurrent control group, and/or different outcomes of 
interest, but with fair to good internal and external validity are discussed below. 
Loranzo and associates, in a randomized controlled trial, studied 638 
patients aged 3-15 identified through an automated claims and pharmacy data 
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search. Patients from 42 primary care centers in Seattle, Chicago and 
Massachusetts with any asthma related encounter were eligible, including 
emergency department visits, hospitalizations or ambulatory encounters. Patients 
with only ambulatory encounters also required use of two or more asthma 
medications during the same time period. The study consisted of two separate 
intervention arms, with entire practices being randomized to one of the 
intervention arms or control. The Peer Leader Education Intervention involved 
training one physician to serve as "asthma champion" in his respective practice, 
sharing guidelines and other information with colleagues, as well as encouraging 
implementation. The Planned Care Intervention consisted of planned asthma care 
visits with a trained asthma nurse who supported and participated in care 
planning, provided self-management techniques and telephone follow-up. Study 
and control groups were comparable at baseline. Data was collected by 
interviews which ascertained medication use, possession of written care plans, 
asthma symptoms days in past fourteen days and oral steroid bursts. Outcomes 
were gathered by telephone survey every eight weeks by blinded research 
assistants. Parental recall was used for number of ASD-14, medication class and 
how frequently medications were used. The peer leader education coordinator 
documented peer leader reports of asthma-related activities through telephone 
contacts every one to two months. Asthma nurses tracked planned asthma care 
visits and telephone calls on laptop database. 
The results of the study showed that case management can have a 
beneficial affect on asthma symptoms. Children in peer leader arm had 6.5 fewer 
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symptom days per year 95%CI ( -16.9 to 3.6), a non-significant difference, but had 
36% (11% to 54%) lower oral steroid burst per year than children with usual care. 
Children in planned care arm had 13.3 ( -24.7 to -2.1) fewer symptom days 
annually (-12% from baseline, p=0.02) and a 39% (11% to 58%) lower oral 
steroid burst rate per year relative to usual care. Planned care subjects had greater 
controller adherence (parent report) compared with usual care subjects RR=1.05 
(1 to 1.09). This study was limited by a high frequency of drop-outs in the 
planned care intervention; specifically, of the 84 total who withdrew from the 
study, half were from this group. 13 
Kelly and associates, in a controlled, nonrandomized trial examining 80 
children aged 2-16 enrolled in Medicaid with frequent emergency department use 
for asthma attempted to evaluate health care and financial outcomes in a 
population of Medicaid-insured asthmatic children after enrollment in a 
comprehensive asthma intervention program. Children were identified through a 
monthly review of emergency department visits and hospital admissions to the 
Children's Hospital of The King's Daughters (CHKD) in Norfolk, VA using 
computerized medical records between March and November 1995. Eligibility 
criteria included the following: I) seen in CHKD ED two or more times or 
hospitalized for asthma at least once in previous year, 2) between 2 and 16, 3) 
insurance coverage through Medicaid, 4) primary care received in the CHKD 
outpatient clinic and 5) not evaluated by an asthma specialist in the preceding 2 
years. Children in both groups received usual care by their primary care 
physician, who was not restricted from referral or other education interventions 
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during study period. The intervention group was enrolled into an education and 
outreach program, which consisted of one-on-one education in a clinic by 
physician and outreach nurse, identification of specific triggers and a written 
asthma plan. Monthly contacts were performed by an outreach nurse, who 
inquired about the patient's health status and medications, as well as arranging 
follow-up visits and providing transportation assistance. Subjects were not 
randomized; however, there were no significant differences in age, sex, race, 
smoking exposure in the home, or phone access. A higher proportion of control 
group compared with intervention were using an anti-inflammatory medication. 
There were also no significant differences in emergency department visits, 
hospitalizations and costs in the year prior to the study. Subjects and initial 
interviewers were blinded to allocation at recruitment. 
Kelly and associates found that enrollment in a comprehensive asthma 
intervention program resulted in a decrease in emergency department visits to a 
mean of 1.7 per patient (p<0.05) in the intervention group and 2.4 in controls 
(from 3.5). Hospitalizations decreased to a mean of0.2 (p<0.001) per patient in 
intervention and 0.5 in controls (from 0.6). Average hospital days decreased from 
2.4 to 0.9 (p<0.001). None of these results were significant for the control group. 
Further, health care charges decreased by $721/child!year in the intervention, 
versus a decrease of $178/child/year in the control group. This study was 
somewhat limited by its lack of randomization, a possibly sicker or less motivated 
control group and no intention to treat calculations. 14 
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Georgiou and associates, in a longitudinal study of a randomly selected 
cohort, attempted to determine the impact of an asthma management program on 
pediatric asthmatics and their caregivers. They identified 401 children with 
asthma in seventeen regional insurance markets by searching medical and 
pharmacy administrative claims data. Children were included in the study if they 
fulfilled one of the following criteria: 1) one or more claim with ICD-9-CM 
primary or secondary diagnosis code of 493.xx, 2) patient had asthma-related 
medical procedure, 3) patient had two or more prescriptions for asthma-related 
class of drugs. Those identified were asked to complete surveys before and after 
participation in a tailored asthma management program developed through United 
Healthcare, which included educational mailings, reminder aids, videos, peak 
expiratory flow rate meter, and telephonic case management. These mailed 
surveys consisted of the Asthma Quality Assessment System, a battery of self-
reported indicators to be filled out by the parent and the ITG Child Asthma Short 
Form, which is concerned with process measures, and quality oflife indicators. 
The authors found that participation in an asthma management program 
reduced emergency department claims from 9.7% to 5.5% (p<0.05). Also, 
responses to surveys indicated significant improvement in daytime and nighttime 
symptoms, functional limitations and impact on family activity. However, it is 
important to note that the study was limited by an overall 28% survey response 
rate and opportunity for recall bias in the survey15 
Chan and associates, in a cohort study of79 children, examined the 
effectiveness of a coordinated, multidisciplinary program for managing asthma. 
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Dependents of military members on Oahu who were inpatients at the Tripier 
Army Medical Center with a respiratory illness were screened for asthma. 
Between November 1997 and January 1999, 210 inpatient children were screened, 
with 79 enrolled in the Military Community Asthma Program (Mil CAP). 
Mil CAP was created from representatives from the base primary care centers, 
respiratory therapists, social workers, psychologists, nurses, nutritionists and 
representatives from utilization management. The program included formal 
teaching and asthma action plans for inpatients diagnosed with asthma, as well as 
case review by a pulmonologist. Also, seminars were provided for pediatricians 
and the pediatric house staff on the diagnosis and management of asthma. 
The authors found that 90% of the Mil CAP participants were notre-
hospitalized in the ensuing two years. Further, in 1997 the hospitalization rate for 
pediatric asthma to the Tripier Army Medical Center was 3.2 per 1000, with 
population and general admission rates not differing significantly over the 1992-
97 period. In 1998, the rate decreased to 2.1 per 1000 (OR=l.66, 1.29-2.0) and in 
1999, it decreased to 1.9 per 1000 (OR=I.75, 1.4-2.2). This study was limited by 
an inadequate description of participant characteristics and a lack of 
generalizability. 16 
Preliminary data from the Harlem Children's Zone Asthma Initiative 
(HCZAI) also supports the use of case management in the care of asthma. 
Created to reduce asthma morbidity and improve proper health services utilization 
for children aged _::12 years living in a 60-block radius of Central Harlem, the 
HCZAI program utilizes a pediatric team of community workers, social workers, 
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nurses and physicians offering medical, educational, environmental, social, and 
legal services to emolled families. Emolled participants (n=314) were managed 
through home visits and monitoring of selected asthma symptom indicators. Data 
collected from 2001-2004 included decreased school absences reported by the 
guardians of emollees during the preceding 14 days, both for any reason (from 
34.4% to 16.0% in 18 months) and because of asthma (from 23.3% to 8.0% in 18 
months). Also, emergency department and unscheduled physician office visits for 
asthma decreased from 35.0% to 8.0% in 18 months. These preliminary data 
suggest improved patient management; however, the study had only a 10% 
participation rate of those screened and possible recall bias on some of the 
outcomes. The authors also cited other limitations, including lack of parent belief 
in their child's asthma diagnosis, parents not emolling their children and problems 
with home visitsn 
The evidence from these trials is supported by my review, as well. 
Hughes and associates reported improved lung function, less days in the hospital 
and decreased school absenteeism, while Evans and associates showed decreased 
maximum symptom days. Considering the results of this systematic review in 
light of the decrease in patient morbidity and the saved health care dollars, a lack 
of statistical significance in the selected measurements does not correlate to a lack 
of clinical and public health significance. Further, it is important to recognize that 
case management, with its emphasis on changing individual patient outcomes 
over time, may be more adequately assessed in longitudinal studies. Irregardless, 
case management for pediatric asthma has been shown to save money and reduce 
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morbidity in some studies. The noted downward trend in emergency department 
and hospitalization utilization, however, is up to debate. Future randomized, 
controlled studies with adequate power to measure these outcomes would be 
helpful, but not necessary, as the majority of evidence is favorable for asthma 
case management. 
This study had several limitations, most importantly the inclusion of only 
one reviewer. Despite the attempt to remain systematic in the methods, it is quite 
possible that some of the author's biases may have affected the review. Further, 
this study was extremely limited in terms of selected outcomes and very tight 
eligibility requirements. This review may have provided more useful information 
had more studies been permitted or a meta-analysis feasible. 
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APPENDIXC 
Access II/III: Community Care of North Carolina 
Medicaid: An Overview 
In 1965, the United States Congress created Medicaid as part of an 
amendment to the Social Security Act. Providing a vehicle for govermnental 
assistance to states' medical care for the poor, Medicaid requires states to satisfy 
minimum coverage requirements, but allows considerable flexibility for 
individual state designs. 
Medicaid is supported by a combination of state and federal funding. The 
program is voluntary for states, but the federal govermnent provides an incentive 
by covering a large proportion of the program's costs. In order to participate in 
the program, each state must finance basic services for enrollees, including 
hospital care and nursing home care, physician services, lab and X-ray services, 
immunizations/preventive services for children, family planning services, prenatal 
care, various services provided at federally approved community health centers 
and nurse midwife/nurse practitioner services. States have the option, as well, to 
provide additional services such as prescription drug coverage, dental care, etc. 
The federal govermnent requires that the states participating in Medicaid 
enroll certain categories of people (Table 1 ). Medicaid eligibility focuses on low-
income families with children and the medically needy. The federal govermnent 
also allows states to enroll certain "categorically needy" or "medically needy" 
individuals, similar to the mandatory groups, but with less stringent eligibility 
criteria. 1'2'3'4 
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Table I. Federally Mandaged Eligibility for Medicaid 
Low-income families whose incomes fall below the federal poverty line (formerly those receiving AFDC) 
Women who are pregnant or have children under the age of 6 and whose family income is below 133% of federal poverty 
level 
Aged, blind and disabled persons receiving Supplemental Security Income (SSI) 
Persons eligible for Medicare whose income is below the FPL 
Selected persons who have lost cash assistance 
Children up to age 21 in certain low-income families 
Persons who are not citizens but who meet other eligibility requirements (for emergency services only) 
Source: Winslow, A. 11ze financing of the U.S. health care industry. Harvard Business School Publishing. Boston. 1998.4 
North Carolina Medicaid and the Carolina Access Program 
North Carolina received approval for its Medicaid State Plan in 1969. 
Since then, the state Medicaid plan has been reviewed and updated yearly by the 
North Carolina General Assembly in terms of eligibility and benefit coverage. 
Currently under the auspices of the Department of Health and Human Services in 
the Division of Medical Assistance (DMA), the North Carolina Medicaid program 
has expanded greatly since its creation. From 1978 to 2002, the number of people 
eligible for Medicaid has increased from 456,000 to I ,390,028 with an increase in 
expenditures from $307 million to $7.4 billion.5 
Carolina Access was created in 1991 as a primary care case management 
program (PCCM), with the goal of linking Medicaid recipients to a medical home 
and primary care physician. Currently, all of the state's counties are involved in 
the program, with each participating physician receiving an extra $2.00 pmpm for 
each eligible Medicaid recipient they manage. However, this program was not a 
fully capitated program involving tertiary care hospitals and networks of 
physicians, and no effort to focus on quality improvement was provided. 
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In 1998, North Carolina created the Community Care Program, with 
emphasis on disease management and care coordination models to improve care 
and decrease costs. Often referred to as Access IVIII, Community Care of North 
Carolina (CCNC) involves provider-led community networks that include local 
PCPs, a local hospital, the Department of Social Services and the health 
department. 
Both Access II and III are coordinated through a non-profit corporation 
that allocates the state funding at a county level and coordinates services. In some 
counties, PCPs have the option to choose between the traditional Access I and 
Access II, while in some sites all physicians are enrolled in Access II. These 
sites, completely comprised of physicians choosing CCNC, are referred to as 
Access III. Physicians, whether in Access II or Access III, receive a higher 
capitation rate of $2.50 pmpm; however, it is important to note that this program 
is not fully capitated. 
Each county department of social services is responsible for enrolling 
individuals into Access I or CCNC. Enrollment in Access I or IVIII is mandatory 
for most children and their families, as well as the disabled and blind who are 
under 65 years of age. Medicaid enrollees who received Medicare, pregnant 
women or foster children may opt for Access; persons residing in a nursing 
facility, are over age 65 and living in adult care facilities, illegal aliens and 
refugees are ineligible for Carolina Access. 6 
CCNC employs population-based health management, designed to identify 
high-risk patients and improve management. In order to do this, the state creates 
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specific disease management initiatives, chosen based on numbers of enrollees 
with the condition, possible room for improvement, the presence of evidence-
based practices, effectiveness of patient education and physician support, among 
others. The initial three initiatives included childhood asthma, diabetes and 
unnecessary emergency department use. 
Each disease management initiative is comprised of seven parts: 
development and implementation of a local disease management team; 
identification of high risk individuals though inpatient and emergency department 
use, chart audits or referrals; development of a treatment plan consisting of 
standard protocols; patient education; individualized care coordination services; 
working with other community agencies to manage the patient's care; and 
collection of performance data to provide feedback to providers. Specific 
examples for each of these steps, as they relate to asthma management, are 
provided in Table 2. 
Primary care physicians in CCNC, or other back-up providers, provide 
regular care for patients and are available 24-hours a day, 7-days a week. PCPs 
must follow disease management initiatives and clinical guidelines; each office 
may delegate responsibility for these efforts as it sees fit. Further, some of the 
money for each site must be used to hire local care coordinators, who may be 
nurses, social workers or lay persons. Those care coordinators perform chart 
audits to assure that local providers are following the state guidelines, identify at-
risk enrollees, perform health assessments, help with patient education, arrange 
patient follow-up and address patients' psychosocial needs. Out of the 
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approximately 2,500 patients they are responsible for, each care coordinator has 
an active case-load of 150-200 patients who require case management. 
Table 2. Components of Asthma Disease Management 
Disease Management Component 
Development and implementation of a local 
disease management team 
Identification of high risk individuals 
Development of a treatment plan consisting of 
standard protocols 
Patient education 
Individualized care coordination services 
Working with other community agencies and 
provides to manage the patient's care 
Collection of performance data to provide 
feedback to providers 
Asthma Disease Management 
Initiative 
• One person at site is designated as asthma 
quality improvement expert 
• State provides clinical training on disease 
management for care coordinators 
• State provides network with list of all 
enrollees with asthma, extracted from claims 
data 
• Providers educated on asthma staging, 
management, Vlfiting asthma action plan, and 
proper medication use 
• Patients and families taught to use peak flow 
meter, inhalers, spacers 
• Given information on asthma triggers 
• Given copy of asthma action plan 
• Care coordinator home visits for those at high 
risk or with frequent emergency department use 
• Care coordinators identify children with 
difficulties managing asthma 
• Care coordinators perform environmental 
assessments, provide education 
• Local schools and/or day care provided with 
copy of asthma action plan 
• Outcome measures: inpatient admission rates, 
inpatient admission rates for asthma, 
emergency department utilization, emergency 
department utilization for asthma 
• Process measures: proportion of asthma 
patients staged, proportion of asthma patients 
staged as II, Ill, or IV on corticosteroids, the 
proportion of asthma patients with asthma 
management plan, percent of asthma patients 
receiving annual influenza vaccine 
• Semi-annual chart audits 
Adapted from Silberman P, Poley S, Slifkin R. Innovative primary care case management programs operating in rural 
communities: case studies of three states. North Carolina Rural Health Research and Policy Analysis Program, Cecil G. 
Sheps Center for Health Services Research. University of North Carolina at Chapel Hill. 2003; Working Paper No. 76.6 
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As of August 2002, CCNC was responsible for 27% of North Carolina's 
Medicaid enrollees. Spread over fourteen care networks, CCNC is considered by 
DMA to better meet the needs of each local Medicaid population, while 
maintaining safety-net providers and improving both the quality and cost-
effectiveness of care. 7•8 
In the case of asthma, CCNC seems to be improving provider practice and 
patient outcomes. A study examining the four systems of North Carolina 
Medicaid delivery (Carolina ACCESS, CCNC, HMOs and fee-for-service) in the 
treatment of persistent pediatric asthma from 1998 to 1999 reported that 67% of 
enrollees in CCNC were receiving appropriate long-term control asthma meds, 
compared with 58% in Carolina ACCESS, 53% in fee-for-service and 53% in the 
HMOs. These significant differences suggested that pediatric enrollees in CCNC 
were more likely to have proper asthma treatment than other groups9 
In a state-wide evaluation of CCNC from January 2000 to December 
2002, children with asthma had lower total health care costs per member per 
month (pmpm) than pediatric asthmatics enrolled in Carolina ACCESS during the 
same time period. Emergency department utilization was also substantially lower 
for CCNC asthmatic children than ACCESS children, with 34% fewer per-
enrollee emergency department visits and 21% fewer per-enrollee asthma-related 
inpatient hospitalizations in 2002. Average number of emergency department 
visits per 1,000 pediatric asthmatics enrolled in CCNC also decreased during this 
time period, with 843 such visits in 2000, 808 visits in 2001 and 679 visits in 
2002. Decreases were also seen in the average number of inpatient admissions 
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per 1,000 pediatric asthmatic enrollees; there were 158 visits per 1,000 enrollees 
in 2000, decreasing to 128 in 2001 and 97 in 2002w 
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